Contraceptive Drugs and Devices Market Size, Trends, Analysis, and Outlook By Drugs (Oral Contraceptives, Topical Contraceptives, Contraceptive Injectable), By Device (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, IUD, Others), By Gender (Male, Female), by Region, Country, Segment, and Companies, 2024-2030
The global Contraceptive Drugs and Devices market size is poised to register 6.88% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study analyzes the global Contraceptive Drugs and Devices market across By Drugs (Oral Contraceptives, Topical Contraceptives, Contraceptive Injectable), By Device (Condoms, Diaphragms, Cervical Caps, Sponges, Vaginal Rings, IUD, Others), By Gender (Male, Female).
The contraceptive drugs and devices market is expected to experience robust growth, propelled by increasing awareness regarding family planning, rising adoption of contraception methods, and expanding access to reproductive healthcare services worldwide. With a focus on contraceptive efficacy, safety, and user convenience, pharmaceutical companies and medical device manufacturers are developing a wide range of hormonal and non-hormonal contraceptives, including oral contraceptives, intrauterine devices (IUDs), implants, and contraceptive patches. Additionally, advancements in contraceptive technology, such as long-acting reversible contraceptives (LARCs) and novel drug delivery systems, are driving market expansion as individuals and healthcare providers seek reliable and reversible contraception options to meet diverse family planning needs and preferences.
Contraceptive Drugs and Devices Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Contraceptive Drugs and Devices market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Contraceptive Drugs and Devices survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Contraceptive Drugs and Devices industry.
Key market trends defining the global Contraceptive Drugs and Devices demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Contraceptive Drugs and Devices Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Contraceptive Drugs and Devices industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Contraceptive Drugs and Devices companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Contraceptive Drugs and Devices industry
Leading Contraceptive Drugs and Devices companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Contraceptive Drugs and Devices companies.
Contraceptive Drugs and Devices Market Study- Strategic Analysis Review
The Contraceptive Drugs and Devices market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
The Contraceptive Drugs and Devices industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Contraceptive Drugs and Devices Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Contraceptive Drugs and Devices Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Contraceptive Drugs and Devices market segments. Similarly, Strong end-user demand is encouraging Canadian Contraceptive Drugs and Devices companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Contraceptive Drugs and Devices market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Contraceptive Drugs and Devices Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Contraceptive Drugs and Devices industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Contraceptive Drugs and Devices market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Contraceptive Drugs and Devices Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Contraceptive Drugs and Devices in Asia Pacific. In particular, China, India, and South East Asian Contraceptive Drugs and Devices markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Contraceptive Drugs and Devices Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Contraceptive Drugs and Devices Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Contraceptive Drugs and Devices market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Contraceptive Drugs and Devices.
Contraceptive Drugs and Devices Market Company Profiles
The global Contraceptive Drugs and Devices market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie (Allergan PLC), Agile Therapeutics, Ani Pharmaceuticals Inc, Bayer AG, Church & Dwight Co. Inc, Fuji Latex Co. Ltd, Johnson & Johnson Ltd, Organon, Pfizer Inc, Reckitt Benckiser, Teva Pharmaceuticals Ltd
Recent Contraceptive Drugs and Devices Market Developments
The global Contraceptive Drugs and Devices market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Contraceptive Drugs and Devices Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Others
By Gender
Male
Female
Geographical Segmentation:
AbbVie (Allergan PLC)
Agile Therapeutics
Ani Pharmaceuticals Inc
Bayer AG
Church & Dwight Co. Inc
Fuji Latex Co. Ltd
Johnson & Johnson Ltd
Organon
Pfizer Inc
Reckitt Benckiser
Teva Pharmaceuticals Ltd
Formats Available: Excel, PDF, and PPT
The contraceptive drugs and devices market is expected to experience robust growth, propelled by increasing awareness regarding family planning, rising adoption of contraception methods, and expanding access to reproductive healthcare services worldwide. With a focus on contraceptive efficacy, safety, and user convenience, pharmaceutical companies and medical device manufacturers are developing a wide range of hormonal and non-hormonal contraceptives, including oral contraceptives, intrauterine devices (IUDs), implants, and contraceptive patches. Additionally, advancements in contraceptive technology, such as long-acting reversible contraceptives (LARCs) and novel drug delivery systems, are driving market expansion as individuals and healthcare providers seek reliable and reversible contraception options to meet diverse family planning needs and preferences.
Contraceptive Drugs and Devices Market Drivers, Trends, Opportunities, and Growth Opportunities
This comprehensive study discusses the latest trends and the most pressing challenges for industry players and investors. The Contraceptive Drugs and Devices market research analyses the global market trends, key drivers, challenges, and opportunities in the industry. In addition, the latest Future of Contraceptive Drugs and Devices survey report provides the market size outlook across types, applications, and other segments across the world and regions. It provides data-driven insights and actionable recommendations for companies in the Contraceptive Drugs and Devices industry.
Key market trends defining the global Contraceptive Drugs and Devices demand in 2024 and Beyond
The industry continues to remain an attractive hub for opportunities for both domestic and global vendors. As the market evolves, factors such as emerging market dynamics, demand from end-user sectors, a growing patient base, changes in consumption patterns, and widening distribution channels continue to play a major role.
Contraceptive Drugs and Devices Market Segmentation- Industry Share, Market Size, and Outlook to 2030
The Contraceptive Drugs and Devices industry comprises a wide range of segments and sub-segments. The rising demand for these product types and applications is supporting companies to increase their investment levels across niche segments. Accordingly, leading companies plan to generate a large share of their future revenue growth from expansion into these niche segments. The report presents the market size outlook across segments to support Contraceptive Drugs and Devices companies scaling up production in these sub-segments with a focus on expanding into emerging countries.
Key strategies adopted by companies within the Contraceptive Drugs and Devices industry
Leading Contraceptive Drugs and Devices companies are boosting investments to capitalize on untapped potential and future possibilities across niche market segments and surging demand conditions in key regions. Further, companies are leveraging advanced technologies to unlock opportunities and achieve operational excellence. The report provides key strategies opted for by the top 10 Contraceptive Drugs and Devices companies.
Contraceptive Drugs and Devices Market Study- Strategic Analysis Review
The Contraceptive Drugs and Devices market research report dives deep into the qualitative factors shaping the market, empowering you to make informed decisions-
- Industry Dynamics: Porter's Five Forces analysis to understand bargaining power, competitive rivalry, and threats that impact long-term strategy formulation.
- Strategic Insights: Provides valuable perspectives on key players and their approaches based on comprehensive strategy analysis.
- Internal Strengths and Weaknesses: Develop targeted strategies to leverage strengths, address weaknesses, and capitalize on market opportunities.
- Future Possibilities: Prepare for diverse outcomes with in-depth scenario analysis. Explore potential market disruptions, technology advancements, and economic changes.
The Contraceptive Drugs and Devices industry report provides a detailed analysis and outlook of revenue generated by companies from 2018 to 2023. Further, with actual data for 2023, the report forecasts the market size outlook from 2024 to 2030 in three case scenarios- low case, reference case, and high case scenarios.
Contraceptive Drugs and Devices Country Analysis and Revenue Outlook to 2030
The report analyses 22 countries worldwide including the key driving forces and market size outlook from 2021 to 2030. In addition, region analysis across Asia Pacific, Europe, the Middle East, Africa, North America, and South America is included in the study. For each of the six regions, the market size outlook by segments is forecast for 2030.
North America Contraceptive Drugs and Devices Market Size Outlook- Companies plan for focused investments in a changing environment
The US continues to remain the market leader in North America, driven by a large consumer base, the presence of well-established providers, and a strong end-user industry demand. Leading companies focus on new product launches in the changing environment. The US economy is expected to grow in 2024 (around 2.2% growth in 2024), potentially driving demand for various Contraceptive Drugs and Devices market segments. Similarly, Strong end-user demand is encouraging Canadian Contraceptive Drugs and Devices companies to invest in niche segments. Further, as Mexico continues to strengthen its trade relations and invest in technological advancements, the Mexico Contraceptive Drugs and Devices market is expected to experience significant expansion, offering lucrative opportunities for both domestic and international stakeholders.
Europe Contraceptive Drugs and Devices Market Size Outlook-Companies investing in assessing consumers, categories, competitors, and capabilities
The German industry remains the major market for companies in the European Contraceptive Drugs and Devices industry with consumers in Germany, France, the UK, Spain, Italy, and others anticipated to register a steady demand throughout the forecast period, driving the overall market prospects. In addition, the proactive approach of businesses in identifying and leveraging new growth prospects positions the European Contraceptive Drugs and Devices market for an upward trajectory, fostering both domestic and international interest. Leading brands operating in the industry are emphasizing effective marketing strategies, innovative product offerings, and a keen understanding of consumer preferences.
Asia Pacific Contraceptive Drugs and Devices Market Size Outlook- an attractive hub for opportunities for both local and global companies
The increasing prevalence of indications, robust healthcare expenditure, and increasing investments in healthcare infrastructure drive the demand for Contraceptive Drugs and Devices in Asia Pacific. In particular, China, India, and South East Asian Contraceptive Drugs and Devices markets present a compelling outlook for 2030, acting as a magnet for both domestic and multinational manufacturers seeking growth opportunities. Similarly, with a burgeoning population and a rising middle class, India offers a vast consumer market. Japanese and Korean companies are quickly aligning their strategies to navigate changes, explore new markets, and enhance their competitive edge. Our report utilizes in-depth interviews with industry experts and comprehensive data analysis to provide a comprehensive outlook of 6 major markets in the region.
Latin America Contraceptive Drugs and Devices Market Size Outlook- Continued urbanization and rising income levels
Rising income levels contribute to greater purchasing power among consumers, spurring consumption and creating opportunities for market expansion. Continued urbanization and rising income levels are expected to sustainably drive consumption growth in the medium to long term.
Middle East and Africa Contraceptive Drugs and Devices Market Size Outlook- continues its upward trajectory across segments
Robust demand from Middle Eastern countries including Saudi Arabia, the UAE, Qatar, Kuwait, and other GCC countries supports the overall Middle East Contraceptive Drugs and Devices market potential. Fueled by increasing healthcare expenditure of individuals, growing population, and high prevalence across a few markets drives the demand for Contraceptive Drugs and Devices.
Contraceptive Drugs and Devices Market Company Profiles
The global Contraceptive Drugs and Devices market is characterized by intense competitive conditions with leading companies opting for aggressive marketing to gain market shares. The report presents business descriptions, SWOT analysis, growth strategies, and financial profiles. Leading companies included in the study are AbbVie (Allergan PLC), Agile Therapeutics, Ani Pharmaceuticals Inc, Bayer AG, Church & Dwight Co. Inc, Fuji Latex Co. Ltd, Johnson & Johnson Ltd, Organon, Pfizer Inc, Reckitt Benckiser, Teva Pharmaceuticals Ltd
Recent Contraceptive Drugs and Devices Market Developments
The global Contraceptive Drugs and Devices market study presents recent market news and developments including new product launches, mergers, acquisitions, expansions, product approvals, and other updates in the industry.
Contraceptive Drugs and Devices Market Report Scope
Parameters: Revenue, Volume Price
Study Period: 2023 (Base Year); 2018- 2023 (Historic Period); 2024- 2030 (Forecast Period)
Currency: USD; (Upon request, can be provided in Euro, JPY, GBP, and other Local Currency)
Qualitative Analysis
- Pricing Analysis
- Value Chain Analysis
- SWOT Profile
- Market Dynamics- Trends, Drivers, Challenges
- Porter’s Five Forces Analysis
- Macroeconomic Impact Analysis
- Case Scenarios- Low, Base, High
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Others
By Gender
Male
Female
Geographical Segmentation:
- North America (3 markets)
- Europe (6 markets)
- Asia Pacific (6 markets)
- Latin America (3 markets)
- Middle East Africa (5 markets)
AbbVie (Allergan PLC)
Agile Therapeutics
Ani Pharmaceuticals Inc
Bayer AG
Church & Dwight Co. Inc
Fuji Latex Co. Ltd
Johnson & Johnson Ltd
Organon
Pfizer Inc
Reckitt Benckiser
Teva Pharmaceuticals Ltd
Formats Available: Excel, PDF, and PPT
1. EXECUTIVE SUMMARY
1.1 Contraceptive Drugs and Devices Market Overview and Key Findings, 2024
1.2 Contraceptive Drugs and Devices Market Size and Growth Outlook, 2021- 2030
1.3 Contraceptive Drugs and Devices Market Growth Opportunities to 2030
1.4 Key Contraceptive Drugs and Devices Market Trends and Challenges
1.4.1 Contraceptive Drugs and Devices Market Drivers and Trends
1.4.2 Contraceptive Drugs and Devices Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Contraceptive Drugs and Devices Companies
2. CONTRACEPTIVE DRUGS AND DEVICES MARKET SIZE OUTLOOK TO 2030
2.1 Contraceptive Drugs and Devices Market Size Outlook, USD Million, 2021- 2030
2.2 Contraceptive Drugs and Devices Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. CONTRACEPTIVE DRUGS AND DEVICES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. CONTRACEPTIVE DRUGS AND DEVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Others
By Gender
Male
Female
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Contraceptive Drugs and Devices Market, 2025
5.2 Asia Pacific Contraceptive Drugs and Devices Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Contraceptive Drugs and Devices Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Contraceptive Drugs and Devices Market, 2025
5.5 Europe Contraceptive Drugs and Devices Market Size Outlook by Type, 2021- 2030
5.6 Europe Contraceptive Drugs and Devices Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Contraceptive Drugs and Devices Market, 2025
5.8 North America Contraceptive Drugs and Devices Market Size Outlook by Type, 2021- 2030
5.9 North America Contraceptive Drugs and Devices Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Contraceptive Drugs and Devices Market, 2025
5.11 South America Pacific Contraceptive Drugs and Devices Market Size Outlook by Type, 2021- 2030
5.12 South America Contraceptive Drugs and Devices Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Contraceptive Drugs and Devices Market, 2025
5.14 Middle East Africa Contraceptive Drugs and Devices Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Contraceptive Drugs and Devices Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Contraceptive Drugs and Devices Market Size Outlook and Revenue Growth Forecasts
6.2 US Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Contraceptive Drugs and Devices Industry Drivers and Opportunities
7. CONTRACEPTIVE DRUGS AND DEVICES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. CONTRACEPTIVE DRUGS AND DEVICES COMPANY PROFILES
8.1 Profiles of Leading Contraceptive Drugs and Devices Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie (Allergan PLC)
Agile Therapeutics
Ani Pharmaceuticals Inc
Bayer AG
Church & Dwight Co. Inc
Fuji Latex Co. Ltd
Johnson & Johnson Ltd
Organon
Pfizer Inc
Reckitt Benckiser
Teva Pharmaceuticals Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
1.1 Contraceptive Drugs and Devices Market Overview and Key Findings, 2024
1.2 Contraceptive Drugs and Devices Market Size and Growth Outlook, 2021- 2030
1.3 Contraceptive Drugs and Devices Market Growth Opportunities to 2030
1.4 Key Contraceptive Drugs and Devices Market Trends and Challenges
1.4.1 Contraceptive Drugs and Devices Market Drivers and Trends
1.4.2 Contraceptive Drugs and Devices Market Challenges
1.5 Competitive Landscape and Key Players
1.6 Competitive Analysis- Growth Strategies Adopted by Leading Contraceptive Drugs and Devices Companies
2. CONTRACEPTIVE DRUGS AND DEVICES MARKET SIZE OUTLOOK TO 2030
2.1 Contraceptive Drugs and Devices Market Size Outlook, USD Million, 2021- 2030
2.2 Contraceptive Drugs and Devices Incremental Market Growth Outlook, %, 2021- 2030
2.3 Segment Snapshot, 2024
3. CONTRACEPTIVE DRUGS AND DEVICES MARKET- STRATEGIC ANALYSIS REVIEW
3.1 Porter's Five Forces Analysis
* Threat of New Entrants
* Threat of Substitutes
* Intensity of Competitive Rivalry
* Bargaining Power of Buyers
* Bargaining Power of Suppliers
3.2 Value Chain Analysis
3.3 SWOT Analysis
4. CONTRACEPTIVE DRUGS AND DEVICES MARKET SEGMENTATION ANALYSIS AND OUTLOOK
4.1 Market Segmentation and Scope
4.2 Market Breakdown by Type, Application, and Other Segments, 2021-2030
By Drugs
Oral Contraceptives
Topical Contraceptives
Contraceptive Injectable
By Device
Condoms
Diaphragms
Cervical Caps
Sponges
Vaginal Rings
IUD
Others
By Gender
Male
Female
4.3 Growth Prospects and Niche Opportunities, 2023- 2030
4.4 Regional comparison of Market Growth, CAGR, 2023-2030
5. REGION-WISE MARKET OUTLOOK TO 2030
5.1 Key Findings for Asia Pacific Contraceptive Drugs and Devices Market, 2025
5.2 Asia Pacific Contraceptive Drugs and Devices Market Size Outlook by Type, 2021- 2030
5.3 Asia Pacific Contraceptive Drugs and Devices Market Size Outlook by Application, 2021- 2030
5.4 Key Findings for Europe Contraceptive Drugs and Devices Market, 2025
5.5 Europe Contraceptive Drugs and Devices Market Size Outlook by Type, 2021- 2030
5.6 Europe Contraceptive Drugs and Devices Market Size Outlook by Application, 2021- 2030
5.7 Key Findings for North America Contraceptive Drugs and Devices Market, 2025
5.8 North America Contraceptive Drugs and Devices Market Size Outlook by Type, 2021- 2030
5.9 North America Contraceptive Drugs and Devices Market Size Outlook by Application, 2021- 2030
5.10 Key Findings for South America Contraceptive Drugs and Devices Market, 2025
5.11 South America Pacific Contraceptive Drugs and Devices Market Size Outlook by Type, 2021- 2030
5.12 South America Contraceptive Drugs and Devices Market Size Outlook by Application, 2021- 2030
5.13 Key Findings for Middle East and Africa Contraceptive Drugs and Devices Market, 2025
5.14 Middle East Africa Contraceptive Drugs and Devices Market Size Outlook by Type, 2021- 2030
5.15 Middle East Africa Contraceptive Drugs and Devices Market Size Outlook by Application, 2021- 2030
6. COUNTRY-WISE MARKET SIZE OUTLOOK TO 2030
6.1 US Contraceptive Drugs and Devices Market Size Outlook and Revenue Growth Forecasts
6.2 US Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.3 Canada Market Size Outlook and Revenue Growth Forecasts
6.4 Canada Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.6 Mexico Market Size Outlook and Revenue Growth Forecasts
6.6 Mexico Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.7 Germany Market Size Outlook and Revenue Growth Forecasts
6.8 Germany Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.9 France Market Size Outlook and Revenue Growth Forecasts
6.10 France Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.11 UK Market Size Outlook and Revenue Growth Forecasts
6.12 UK Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.13 Spain Market Size Outlook and Revenue Growth Forecasts
6.14 Spain Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.16 Italy Market Size Outlook and Revenue Growth Forecasts
6.16 Italy Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.17 Rest of Europe Market Size Outlook and Revenue Growth Forecasts
6.18 Rest of Europe Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.19 China Market Size Outlook and Revenue Growth Forecasts
6.20 China Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.21 India Market Size Outlook and Revenue Growth Forecasts
6.22 India Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.23 Japan Market Size Outlook and Revenue Growth Forecasts
6.24 Japan Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.26 South Korea Market Size Outlook and Revenue Growth Forecasts
6.26 South Korea Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.27 Australia Market Size Outlook and Revenue Growth Forecasts
6.28 Australia Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.29 South East Asia Market Size Outlook and Revenue Growth Forecasts
6.30 South East Asia Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.31 Rest of Asia Pacific Market Size Outlook and Revenue Growth Forecasts
6.32 Rest of Asia Pacific Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.33 Brazil Market Size Outlook and Revenue Growth Forecasts
6.34 Brazil Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.36 Argentina Market Size Outlook and Revenue Growth Forecasts
6.36 Argentina Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.37 Rest of South America Market Size Outlook and Revenue Growth Forecasts
6.38 Rest of South America Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.39 Middle East Market Size Outlook and Revenue Growth Forecasts
6.40 Middle East Contraceptive Drugs and Devices Industry Drivers and Opportunities
6.41 Africa Market Size Outlook and Revenue Growth Forecasts
6.42 Africa Contraceptive Drugs and Devices Industry Drivers and Opportunities
7. CONTRACEPTIVE DRUGS AND DEVICES MARKET OUTLOOK ACROSS SCENARIOS
7.1 Low Growth Case
7.2 Reference Growth Case
7.3 High Growth Case
8. CONTRACEPTIVE DRUGS AND DEVICES COMPANY PROFILES
8.1 Profiles of Leading Contraceptive Drugs and Devices Companies in the Market
8.2 Business Descriptions, SWOT Analysis, and Growth Strategies
8.3 Financial Performance and Key Metrics
AbbVie (Allergan PLC)
Agile Therapeutics
Ani Pharmaceuticals Inc
Bayer AG
Church & Dwight Co. Inc
Fuji Latex Co. Ltd
Johnson & Johnson Ltd
Organon
Pfizer Inc
Reckitt Benckiser
Teva Pharmaceuticals Ltd
9. APPENDIX
9.1 Scope of the Report
9.2 Research Methodology and Data Sources
9.3 Glossary of Terms
9.4 Market Definitions
9.5 Contact Information
